Roles of neuropathology-associated reactive astrocytes: a systematic review.

Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR. · 2023

Read Roles of neuropathology-associated reactive astrocytes: a systematic review. by Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10009953.txt.

Introduction

Lawrence and colleagues review the roles of reactive astrocytes in brain disease in a 2023 systematic review. Astrocytes are star-shaped support cells in the brain. After injury or during inflammation, signals from other brain cells can push them into a toxic state that harms nearby nerve cells.

The review pulls together studies on this harmful form and on milder reactive forms. It asks when these cells protect the brain and when they drive damage. The paper gives a balanced guide to a debate that shapes research on stroke, infection, and memory loss.

Catalog record

CREATORLawrence JM, Schardien K, Wigdahl B, Nonnemacher MR.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE150 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10009953

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Roles of neuropathology-associated reactive astrocytes: a systematic review By Jill M Lawrence, Kayla Schardien, Brian Wigdahl, Michael R Nonnemacher Published in: Acta Neuropathologica Communications DOI: 10.1186/s40478-023-01526-9 ABSTRACT Abstract In the contexts of aging, injury, or neuroinflammation, activated microglia signaling with TNF-α, IL-1α, and C1q induces a neurotoxic astrocytic phenotype, classified as A1, A1-like, or neuroinflammatory reactive astrocytes. In contrast to typical astrocytes, which promote neuronal survival, support synapses, and maintain blood–brain barrier integrity, these reactive astrocytes downregulate supportive functions and begin to secrete neurotoxic factors, complement components like C3, and chemokines like CXCL10, which may facilitate recruitment of immune cells across the BBB into the CNS. The proportion of pro-inflammatory reactive astrocytes increases with age through associated microglia activation, and these pro-inflammatory reactive astrocytes are particularly abundant in neurodegenerative disorders. As the identification of astrocyte phenotypes progress, their molecular and cellular effects are characterized in a growing array of neuropathologies. Keywords: Neurotoxic reactive astrocytes, Activated astrocytes, A1 astrocytes, Neuroinflammation, Neurodegeneration ASTROCYTE BIOLOGY History The cellular environment of the central nervous system (CNS) is dominated by the ubiquitous presence of star-shaped glia cells. When first described by Rudolph Virchow in 1858, what he termed neuroglia were initially thought to be a form of connective tissue, the abundance of which simply served to hold neurons together like “glue” [2, 95]. In reality, the eponymous astrocytes perform a wide variety of critical functions that support neurons (cells that collectively comprise the circuitry responsible for brain function), synapses (physiological space between signaling neurons in which neurotransmission occurs), and the blood–brain barrier (a protective cellular layer that envelops blood vessels in the CNS), making them essential for maintaining CNS homeostasis. Astrocyte functions Astrocytes promote survival of neurons and myelin-producing oligodendrocytes through the secretion of neurotrophic growth factors [2]. Synapse formation, pruning, and remodeling are all regulated by astrocyte functions, and established synapses continue to be strictly regulated by astrocytes. The broad topic of astrocyte biology and function is explored in a comprehensive review by Sofroniew and Vinters [113]. Briefly, to protect and support electrochemical neurotransmission, astrocytes extend processes that envelop the space between pre-synaptic and post-synaptic neurons, forming a tripartite synapse [2, 6, 113]. Rather than firing an action potential in response to excitation, astrocytes respond with a sharp increase in intracellular Ca2+ concentrations and the release of signaling gliotransmitters, such as glutamate and purines, or neuroactive steroids into the synaptic cleft to excite neurons, or to other astrocytes [113]. To prevent excitotoxicity, astrocytes assist with the termination of neuronal signaling via uptake of excess neurotransmitters from the synaptic space through densely clustered transporters expressed on astrocytic processes [40, 113]. Once taken up, the neurotransmitter is subsequently broken down and the inactive precursor components are released back into the synaptic cleft, where they are recycled by the neurons for future signaling [40]. As the most abundant cell type in the brain, astrocytes can form bidirectional contacts with both neurons and the microvascular endothelial cells lining cerebral blood vessels. When these associations are simultaneous, the astrocyte is able to transport oxygen, glucose, and other substrates from the blood to the neurons it supports [113]. Astrocytes can modulate local blood flow in response to neuronal activity by releasing vasodilators like nitric oxide or arachidonic acid, increasing blood flow and thus their provision of nutritional support for active neurons [79, 113]. Composed of a layer of microvascular endothelial cells, pericytes, and astrocytes, the blood–brain barrier (BBB) or neurovascular unit surrounds cerebral capillaries and protects the delicate CNS from the periphery while ensuring adequate blood supply [113]. The BBB strictly regulates what enters the brain parenchyma from the blood, with its low permeability maintained by tight junctions between the endothelial cells [78]. Its functional integrity relies on close associations of dense astrocyte processes, or endfeet, that ensheath blood vessel endothelial cells, forming a charged basement membrane, known as the glial limiting membrane [113, 120]. These processes are lined with various ion transporters, junctional proteins, and aquaporin-4 (AQP4), an astrocyte-specific water channel [113, 141]. Astrocytes also maintain integrity of outer and inner cerebrospinal fluid-brain barriers that similarly separate the brain parenchyma from the subarachnoid space and ventricles, respectively [15, 132]. A significant role of the BBB is restriction of peripheral immune cells from invading the CNS on a large scale [106]. Compromised barrier integrity can permit the infiltration of immune cells that release pro-inflammatory cytokines and toxic reactive oxygen species (ROS), leading to destructive neuroinflammation and potential neurodegeneration [106]. Thus, astrocyte function and support of the BBB is essential for protecting against neurotoxic insult. Astrocyte variations and reactivity As opposed to being monolithic in function and morphology, astrocytes differ significantly depending on both tissue and cellular localization. Fibrous astrocytes have long fiber-like processes that associate with nodes of Ranvier along the axons that comprise the white matter, while protoplasmic astrocytes have highly branched processes that associate with neuronal somas and synapses that form the grey matter [2, 113, 120]. While these characterizations have been recognized for some time, functional distinctions have only recently been investigated. Historically, in response to damage, astrocytes have been characterized as adopting a reactive phenotype. In contrast to the typically quiescent state of mature astrocytes, reactive astrocytes can become highly proliferative, and this astrogliosis is the foundation for glial scar formation [5, 33, 75]. The presence of glial fibrillary acidic protein (GFAP), a cytoskeletal intermediate filament, has long been used as an astrocyte-specific marker, with increased GFAP in tissues of diseased or injured brains indicating cell proliferation and thus reactivity [75]. However, GFAP expression levels are known to be fluid and vary significantly from cell to cell, even in the absence of disease [12, 75]. Recently, more advanced and reliable measures of cell division have shown that astrocyte proliferation is not a universal response to all damage, but is instead quite limited in contexts of inflammation and neurodegeneration, regardless of increased GFAP expression [75]. In experiments utilizing proliferation markers, such as BrdU incorporation into newly-synthesized DNA and cell division-associated Ki67 staining, less than 3% of astrocytes responded with increased proliferation in an Alzheimer’s disease (AD) mouse model, and little to no proliferation was detected with treatment with lipopolysaccharide (LPS), an inflammatory signal [2, 54, 75, 142]. Further investigations involving genetic analysis of astrocytes under a variety of stimuli was shown to elicit distinct gene expression patterns [142]. To best support the CNS in a system that can suffer from a variety of insults, astrocytes have seemingly evolved a diverse reactive response. The work of Shane Liddelow and the late Ben Barres identified the genetic and functional changes that astrocytes undergo in response to different stimuli, and the mechanism by which these changes occur. In 2017, Liddelow and Barres reported their discovery of at least two distinct functional phenotypes that quiescent astrocytes can adopt, termed A1 and A2, laying the foundation for the current and evolving understanding of the role of astrocytes in disease [76]. Reactive phenotypic polarization depends on the nature of the inducing stimuli. Rather than eliciting a single response to CNS injury or insult, astrocyte reactivity is highly heterogenous. Borrowing from the nomenclature used to describe reactive macrophages and microglia, in response to tissue damage and ischemia, astrocytes adopt a neuroprotective A2 phenotype [75].

Read the complete text